Determinants of Virologic Failure among Adult HIV Patients on First-Line Antiretroviral Therapy at Waghimra Zone, Northern Ethiopia: A Case-Control Study

被引:12
作者
Emagnu, Abrham [1 ]
Abay, Zenahebezu [2 ]
Bulti, Abera Balcha [2 ]
Animut, Yaregal [3 ]
机构
[1] Waghimra Zone Hlth Dept, Sekota, Ethiopia
[2] Univ Gondar, Sch Med, Dept Internal Med, Coll Med & Hlth Sci, Gondar, Ethiopia
[3] Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Coll Med & Hlth Sci, Gondar, Ethiopia
来源
ADVANCES IN PUBLIC HEALTH | 2020年 / 2020卷
关键词
UNIVERSITY; ADHERENCE; MORTALITY; PROGRAMS; OUTCOMES; SEX; AGE;
D O I
10.1155/2020/1929436
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction. The primary goal of antiretroviral therapy (ART) is to reduce the viral load in HIV-infected patients to promote quality of life, as well as to reduce HIV-related morbidity and mortality. A high rate of virologic failure was reported in Waghimra Zone, Northwest Ethiopia, in viral load assessment conducted among HIV-infected patients on ART in the Amhara region. However, there is limited evidence on the determinants of virological failure in the study area. This study aimed to identify the determinants of virological failure among HIV-infected patients on antiretroviral therapy in Waghimra zone, Northern Ethiopia, 2019.Methods. An institutional-based unmatched case-control study was conducted from May 21 to June 30, 2019. Cases were people living with HIV (PLHIV) on ART who had already experienced virological failure; controls were those without virological failure. Data were extracted from 92 cases and 184 controls through chart review using a pretested and structured checklist. The data were entered using Epi Info version 7 and exported to SPSS version 20 for analysis. A multivariate logistic regression analysis was carried out to identify factors associated with virological failure, and variables with aPvalue Results. This study revealed that poor adherence to ART (adjusted odds ratio (AOR) = 4.24, 95% confidence interval (CI): 2.17, 8.31), taking ART for longer than five years (AOR = 3.11, 95% CI: 1.17, 8.25), having drug toxicity (AOR = 3.34, 95% CI: 1.54, 7.23), age of PLHIV >= 35 years (AOR = 2.45, 95% CI: 1.29,4.64), and recent CD4 count <200 cells/mm(3) (AOR = 3.06, 95% CI: 1.52, 6.13) were factors associated with virologic failure.Conclusion and Recommendation. This study showed that poor adherence to treatment, longer duration on ART, experiencing drug toxicity, older age, and recent CD4 <200 cell/mm(3) are factors that increase the risk of virologic failure.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] HIV-1 virologic failure and acquired drug resistance among first-line antiretroviral experienced adults at a rural HIV clinic in coastal Kenya: a cross-sectional study
    Hassan, Amin S.
    Nabwera, Helen M.
    Mwaringa, Shalton M.
    Obonyo, Clare A.
    Sanders, Eduard J.
    de Wit, Tobias F. Rinke
    Cane, Patricia A.
    Berkley, James A.
    AIDS RESEARCH AND THERAPY, 2014, 11
  • [22] Determinants of late presentation to HIV/AIDS care in Southern Tigray Zone, Northern Ethiopia: an institution based case-control study
    Gelaw, Yalemzewod Assefa
    Senbete, Goitom Halefom
    Adane, Akelew Awoke
    Alene, Kefyalew Addis
    AIDS RESEARCH AND THERAPY, 2015, 12
  • [23] Determinants of virological failure among HIV clients on second-line antiretroviral treatment at Felege-hiwot and University of Gondar comprehensive specialized hospitals in the Amhara Region, Northwest Ethiopia: A case-control study
    Ayenew, Getahun
    Agumas, Yeshambel
    Shibabaw, Tebkew
    Getaneh, Gebremariam
    Getie, Michael
    PLOS ONE, 2024, 19 (07):
  • [24] Tenofovir diphosphate levels in dried blood spots are associated with virologic failure and resistance to first-line therapy in South Africa: a case-control cohort study
    Castillo-Mancilla, Jose R.
    Edwards, Johnathan A.
    Brijkumar, Jaysingh
    Moosa, Mahomed-Yunus
    Zhao, Yuan
    Ofotokun, Igho
    Johnson, Brent A.
    Lee, Mitchell H.
    Pillay, Selvan
    Pillay, Melendhran
    Moodley, Pravi
    Kuritzkes, Daniel R.
    Sunpath, Henry
    Bushman, Lane R.
    Ellison, Lucas
    Anderson, Peter L.
    Marconi, Vincent C.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2021, 24 (12)
  • [25] Magnitude and causes of first-line antiretroviral therapy regimen changes among HIV patients in Ethiopia: a systematic review and meta-analysis
    Ataro, Zerihun
    Motbaynor, Birhanu
    Weldegebreal, Fitsum
    Sisay, Mekonnen
    Tesfa, Tewodros
    Mitiku, Habtamu
    Marami, Dadi
    Teklemariam, Zelalem
    Shewamene, Zewdneh
    BMC PHARMACOLOGY & TOXICOLOGY, 2019, 20 (01)
  • [26] Virologic outcomes of first-line HAART and associated factors among Chinese patients with HIV in three sentinel antiretroviral treatment sites
    Ruan, Yuhua
    Xing, Hui
    Wang, Xia
    Tang, Heng
    Wang, Zhe
    Liu, Hongwei
    Su, Bin
    Wu, Jianjun
    Li, Hanping
    Liao, Lingjie
    Li, Jingyun
    Wu, Julia Wei
    Shao, Yiming
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2010, 15 (11) : 1357 - 1363
  • [27] Antiretroviral Resistance After First-Line Antiretroviral Therapy Failure in Diverse HIV-1 Subtypes in the SECOND-LINE Study
    Lam, Edward P.
    Moore, Cecilia L.
    Gotuzzo, Eduardo
    Nwizu, Chidi
    Kamarulzaman, Adeeba
    Chetchotisakd, Ploenchan
    van Wyk, Jean
    Teppler, Hedy
    Kumarasamy, Nagalingeswaran
    Molina, Jean-Michel
    Emery, Sean
    Cooper, David A.
    Boyd, Mark A.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2016, 32 (09) : 841 - 850
  • [28] Antiretroviral therapy non-adherence among children living with HIV in Dire Dawa, Eastern Ethiopia: a case-control study
    Mengesha, Melkamu Merid
    Embibel, Mulugeta
    Gobena, Tesfaye
    Tunje, Abayneh
    Jerene, Degu
    Hallstrom, Inger Kristensson
    BMC PEDIATRICS, 2022, 22 (01)
  • [29] Effect of Dolutegravir-Based First-Line Antiretroviral Therapy on Mother-to-Child Transmission of HIV Among HIV-Exposed Infants in Ethiopia: a Before-and-After Study
    Facha, Wolde
    Tadesse, Takele
    Wolka, Eskinder
    Astatkie, Ayalew
    HIV AIDS-RESEARCH AND PALLIATIVE CARE, 2024, 16 : 203 - 215
  • [30] Time to First Line Antiretroviral Therapy Adverse Drug Reaction and its Predictors Among Adult HIV/AIDS Patients on Treatment in Eastern Ethiopia
    Weldesenbet, Adisu Birhanu
    Tusa, Biruk Shalmeno
    Debele, Gebiso Roba
    Sisay, Malede Mequanent
    Ayele, Tadesse Awoke
    FRONTIERS IN PHARMACOLOGY, 2022, 13